United States · FDA National Drug Code directory

Irbesartan

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 33342-047_5a240405-5eb7-46ca-811b-d8dd93ee43d3
Product NDC: 33342-047
Form: TABLET
Composition / generic term: Irbesartan
Labeler: Macleods Pharmaceuticals Limited
Marketing category: ANDA
Marketing start / end (source format): 20120927
Source listing expiry: 20271231

Source-listed ingredients

IRBESARTAN — 75 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET in 1 BOTTLE (33342-047-07) · 33342-047-07
90 TABLET in 1 BOTTLE (33342-047-10) · 33342-047-10
10 BLISTER PACK in 1 CARTON (33342-047-12) / 10 TABLET in 1 BLISTER PACK · 33342-047-12
500 TABLET in 1 BOTTLE (33342-047-15) · 33342-047-15
13600 TABLET in 1 POUCH (33342-047-68) · 33342-047-68

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →